TIMP2 and Miyoshi myopathy: Moreover, it was found that miR-483p-5p is upregulated in MM-mesenchymal stem cells (MM-MSCs) and could be transferred from these cells to MM cells via Extracellular Vesicles (EVs), favoring MM progression and related bone disease by targeting tissue inhibitor of metalloproteinase 2 (TIMP2) (Gu et al., 2022).